Sanara MedTech Inc. SMTI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.85% | 12.96% | 17.38% | 18.97% | 30.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.85% | 12.96% | 17.38% | 18.97% | 30.52% |
| Cost of Revenue | -0.14% | -4.49% | -5.88% | -7.60% | 2.82% |
| Gross Profit | 10.69% | 14.53% | 19.63% | 21.73% | 33.54% |
| SG&A Expenses | 12.62% | 8.88% | 5.98% | 6.47% | 12.58% |
| Depreciation & Amortization | 14.19% | -6.96% | -17.27% | -23.95% | -50.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.85% | 7.65% | 4.65% | 4.71% | 7.87% |
| Operating Income | -10.72% | 116.77% | 1,779.95% | 397.35% | 212.43% |
| Income Before Tax | -246.02% | 86.17% | 110.25% | 94.60% | 119.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -246.02% | 86.17% | 110.25% | 94.60% | 119.46% |
| Earnings from Discontinued Operations | 98.45% | -301.71% | -535.81% | -1,403.05% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -96.15% | -94.58% | -88.95% | -93.68% | -95.30% |
| Net Income | 91.96% | -222.15% | -193.82% | -288.66% | -348.29% |
| EBIT | -10.72% | 116.77% | 1,779.95% | 397.35% | 212.43% |
| EBITDA | -5.87% | 72.12% | 455.13% | 2,683.50% | 409.87% |
| EPS Basic | 91.93% | -219.19% | -189.91% | -282.11% | -339.97% |
| Normalized Basic EPS | -128.44% | 262.75% | 149.30% | 123.25% | 121.19% |
| EPS Diluted | 91.44% | -210.73% | -181.85% | -272.10% | -328.42% |
| Normalized Diluted EPS | -129.64% | 255.70% | 148.15% | 122.52% | 120.74% |
| Average Basic Shares Outstanding | 0.77% | 0.75% | 1.03% | 1.08% | 1.70% |
| Average Diluted Shares Outstanding | -0.18% | 1.49% | 3.63% | 2.87% | 3.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |